[1]盛晓芳,管一晖,赵军,等.PET-CT在脑胶质瘤放射治疗靶区确定中的应用[J].国际放射医学核医学杂志,2005,29(6):241-244.
　SHENG Xiao-fang,GUAN Yi-hui,ZHAO Jun,et al.Application of PET-CT in delineation of radiotherapy planning target volume for glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):241-244.
点击复制

PET-CT在脑胶质瘤放射治疗靶区确定中的应用(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
29
期数:
2005年第6期
页码:
241-244
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Application of PET-CT in delineation of radiotherapy planning target volume for glioma
作者:
盛晓芳1;  管一晖2;  赵军2;  左传涛2
1. 200235 上海, 复旦大学附属华山医院肿瘤放疗中心;
2. 200235 上海, 复旦大学附属华山医院核医学PET中心
Author(s):
SHENG Xiao-fang1;  GUAN Yi-hui2;  ZHAO Jun2;  ZUO Chuan-tao2
1. Department of Radiation Oncology, Huashan Hospital, Fudan University, Shanghai 200235, China;
2. Department of PET Center Nuclear Medicine, Huashan Hospital, Fudan University, Shanghai 200235, China
关键词:
正电子发射体层显像; 脑胶质瘤; 放射治疗; 靶区
Keywords:
positron emission tomography; glioma; radiotherapy; target volume
分类号:
R814.42;R817.4
摘要:
脑胶质瘤放射治疗靶区的确定是一个值得研究的课题。现代放射治疗技术快速发展,从物理调强发展到生物调强,照射靶区的确定更为重要。本文阐述了PET-CT在脑胶质瘤放射治疗几何靶区和生物靶区确定中的意义和作用,以及不同示踪剂对靶区显示的不同贡献。
Abstract:
The accurate delineation of radiotherapy planning target volume (PTV) for glioma is always the pursuit of the clinicians. Nowadays the radiotherapy technology is quickly developing, from previous physical modulated intensity radiotherapy to biological modulated intensity radiotherapy, accordingly the accurate delineation of PTV is becoming more and more important. This review will introduce the value and significance of PET in definition of PTV and BTV (biology target volume) and discuss the respective value of different tracer for target volume presentation.

参考文献/References:

1 Ling CC, Humn J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT):biological imaging and biological conformality[J]. Int J Radiat Oncol Biol Phys, 2000, 47(3):551-560.
2 Thornton AF, Sandier HM, Ten Haken RK, et al. The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms[J]. Int J Radiat Oncol Biol Phys, 1992, 24(4):767-775.
3 Bénard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography[J]. Semin Nucl Med, 2003, 33(2):148-162.
4 Pirotte B, Goldman S, Massager N, et al. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas[J]. J Nucl Med, 2004, 45(8):1293-1298.
5 Kracht LW, Miletic H, Busch S, et al. Delineation of brain tumor extent with [11C] L-methionine positron emission tomography:local comparison with stereotactic histopathology[J]. Clin Cancer Res, 2004, 10(21):7163-7170.
6 Levivier M, Massager N, Wikler D, et al. Use of stereotactic PET Images in dosimetry planning of radiosurgery for brain tumors:clinical experience and proposed classification[J]. J Nucl Med,2004, 45(7):1146-1154.
7 Padma MV, Said S, Jacobs M, et al. Prediction of pathology and survival by FDG PET in gliomas[J]. J Neurooncol, 2003, 64(3):227-237.
8 Giammarile F, Houzard C, Bournaud C, et al. High and low grade oligodendrogliomas (ODG):correlation of amino-acid and glucose uptakes using PET and histological classifications[J]. J Neurooncol, 2004, 68(3):263-274.
9 Chen W, Cloughesy T, Kamdar N, et al. Imaging proliferation in brain tumors with 18F-FLT PET:comparison with 18F-FDG[J]. J Nucl Med,2005, 46(6):945-952.
10 Kracht LW, Friese M, Herholz K, et al. Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma[J]. Eur J Nucl Med Mol Imaging, 2003, 30(6):868-873.
11 Dhermain F, Ducreux D, Bidault F, et al. Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma[J]. Bull Cancer, 2005, 92(4):333-342.

相似文献/References:

[1]王洗,刘强.替莫唑胺联合适形放疗治疗恶性脑胶质瘤的临床观察[J].国际放射医学核医学杂志,2009,33(2):128.[doi:10.3760/cma.j.issn.1673-4114.2009.02.020]
[2]王洗,刘强.脑胶质瘤辐射敏感性相关基因的研究进展[J].国际放射医学核医学杂志,2008,32(5):311.
　WANG Xi,LIU Qiang.The progress of radiosensitive genes of human brain glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(6):311.
[3]黄劲雄,吴华.功能性影像在脑胶质瘤放射治疗靶区确定中的应用[J].国际放射医学核医学杂志,2007,31(2):108.
　HUANG Jing-xiong,WU Hua.The functional imaging in target volume delineation of radiotherapy planning for gliomas[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(6):108.
[4]李峰生,陈肖华.RNA干涉治疗脑胶质瘤的研究进展[J].国际放射医学核医学杂志,2007,31(5):300.
　LI Feng-sheng,CHEN Xiao-hua.Research progress on treatment of glioma with RNA interference[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(6):300.
[5]左传涛.脑中风患者脑功能重塑研究中应注意的问题[J].国际放射医学核医学杂志,2005,29(1):1.
　ZUO Chuan-tao.The issues in the study of brain plasticity after stroke[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):1.
[6]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
　CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):10.
[7]董爱生,田建明.部分癫痫的神经影像学诊断[J].国际放射医学核医学杂志,2005,29(4):148.
　DONG Ai-sheng,TIAN Jian-ming.Neuroimaging in the diagnosis of partial epilepsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):148.
[8]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
　JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):197.
[9]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
　CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):201.
[10]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
　WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):205.

备注/Memo

备注/Memo:
收稿日期:2005-07-05。
更新日期/Last Update: 1900-01-01